Correlations between awareness of illness (insight) and history of addiction in heroin-addicted patients

Frontiers in Psychiatry

Volumn 3, Issue JUL, 2012, Pages

  Maremmani, Angelo Giovanni Icro ^a,b   Rovai, Luca ^a   Rugani, Fabio ^a   Pacini, Matteo ^b   Lamanna, Francesco ^c   Bacciardi, Silvia ^a   Perugi, Giulio ^a   Deltito, Joseph ^d,e   Dell'Osso, Liliana ^a   Maremmani, Icro ^a,b,d  

^a UNIVERSITY OF PISA   (Italy)

^b Association for the Application of Neuroscientific Knowledge to Social Aims   (Italy)

^c SerT (Drug Addiction Unit)   (Italy)

^d G DE LISIO INSTITUTE OF BEHAVIOURAL SCIENCES   (Italy)

^e NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Awareness of illness; Compliance to treatment; Heroin addiction; Insight; Mental status; Natural history of addiction; Psychiatry; Severity of illness

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ATTITUDE TO ILLNESS; AWARENESS; CONTROLLED STUDY; DISEASE SEVERITY; EDUCATIONAL STATUS; FEMALE; HELP SEEKING BEHAVIOR; HEROIN DEPENDENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MENTAL HEALTH; PATIENT ATTITUDE; PSYCHOSOCIAL DISORDER; PSYCHOSOMATIC DISORDER; SUBSTANCE ABUSE;

EID: 84866893608     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2012.00061     Document Type: Article

References (81)

1. Akiskal, H. S., and Mallya, G. (1987). Criteria for the 'soft' bipolar spectrum: treatment implications. Psy-chopharmacol Bull. 23, 68-73.
2. Anderson, C. M., Reiss, D. J., and Hog-arty, G. E. (1986). Schizophrenia and the Family: A Practitioner's Guide to Psychoeducation and Management. New York: Guilford Press.
3. APA. (2000). DSM-IV-TR. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association.
4. Beck, A. T., Baruch, E., Balter, J. M., Steer, R. A., and Warman, D. M. (2004). A new instrument for measuring insight: the beck cognitive insight scale. Schizophr. Res. 68, 319-329.
5. Bellack, A. S., and Mueser, K. T. (1993). Psychosocial treatment for schizophrenia. Schizophr. Bull. 19, 317-336.
6. Berger, P. A., Watson, S. J., Akil, H., Elliot, G. R., Rubin, R. T., and Pfefferbaum, A. (1980). Betaendorphin and schizophrenia. Arch. Gen. Psychiatry 37, 635-640.
7. Bodkin, J. A., Zornberg, G. L., Lukas, S. E., and Cole, J. O. (1995). Buprenorphine treatment of refractory depression. J. Clin. Psychophar-macol. 15,49-57.
8. Brousse, G., Garay, R. P., and Benyam-ina, A. (2008). Management of comorbid bipolar disorder and alcohol dependence. Presse Med. 37, 1132-1137.
9. Callaway, E. (1996). Buprenorphine for depression: the un-adoptable orphan. Biol. Psychiatry 39, 989-990.
10. Camprubi, N., Almela, A., and Garre-Olmo,J. (2008). Psychometric properties of the Spanish validation of the insight scale. Actas Esp. Psiquiatr. 36, 323-330.
11. Cassano, G. B., Akiskal, H. S., Musetti, L., Perugi, G., Soriani, A., and Mignani, V. (1989). Psychopathol-ogy, temperament and paste course in primary mayor depression. II Toward a redefinition of bipolarity with a new semistructured interview for depression. Psychopathology 22, 278-288.
12. Clouet, D. H. (1982). A biochemical and neurophysiological comparison of opioids and antipsy-chotics. Ann. N. Y. Acad. Sci. 398, 130-139.
13. Cocores, J. A., Petel, M. D., Gold, M. S., and Pottash, A. C. (1987). Cocaine abuse, attention deficit disorder, and bipolar patients. J. Nerv. Ment. Dis. 175,431-432.
14. Dell'Osso, L., Pini, S., Cassano, G. B., Mastrocinque, C., Seckinger, R. A., Saettoni, M., Papasogli, A., Yale, S. A., and Amador, X. F. (2002). Insight into illness in patients with mania, mixed mania, bipolar depression and major depression with psychotic features. Bipolar Disord. 4, 315-322.
15. Emrich, H. M. (1984). Endorphins in psychiatry. Psychiatr. Dev. 2, 97-114.
16. Engh, J. A., Friis, S., Birkenaes, A. B., Jonsdottir, H., Ringen, P. A., Ruud, T., Sundet, K. S., Opjordsmoen, S., and Andreassen, O. A. (2007). Measuring cognitive insight in schizophrenia and bipolar disorder: a comparative study. BMC Psychiatry 7,71. doi:10.1186/1471-244X-7-71
17. Exstein, I., Pottash, A. L. C., and Gold, M. S. (1982). "A possible opi-oid receptor dysfunction in some depressive disorders," in Opioids in Mental Illness: Theories, Clinical Observations and Treatment Possibilities, ed. K. Verebey (New York, NY: The New York Academy of Sciences), 398
18. Falloon, I. (1988). Comprehensive Management of Mental Disorders. Buckingham: Buckingham Mental Health Service.
19. Falloon, I. (1995). CHIAMA (Community Help to Increase Appropriate Mental Health Services Access). Paper presented at University of L'Aquila on December 15.
20. Falloon, I. R. H., and Fadden, G. (1995). Integrated Mental Health Care: A Comprehensive, Community-Based Approach. Cambridge: Cambridge University Press.
21. Foltin, R. W., and Fischman, M. W. (1996). Effects of methadone or buprenorphine maintenance on the subjective and reinforcing effects of intravenous cocaine in humans. J. Pharmacol. Exp. Ther. 278, 1153-1164.
22. Francis, J. L., and Penn, D. L. (2001). The relationship between insight and social skill in persons with severe mental illness. J. Nerv. Ment. Dis. 189, 822-829.
23. Gerner, R. H., Catlin, D. H., Gorelick, D. A., Hui, K. K., and Li, C. H. (1980). Beta-endorphin. Intravenous infusion causes behavioral change in psychiatric inpatients. Arch. Gen. Psychiatry 37, 642-647.
24. Ghaemi, S. N., Boiman, E., and Goodwin, F. K. (2000). Insight and outcome in bipolar, unipolar, and anxiety disorders. Compr. Psychiatry 41, 167-171.
25. Gold, M. S., Pottash, A. L. C., Sweeney, D. R., Martin, D., and Extein, I. (1982). Antimanic, antidepressant, and antipanic effects of opiate: clinical, neuro-anatomical, and biochemical evidence. Ann. N. Y. Acad. Sci. 398, 140-150.
26. Goldstein, R. Z., Craig, A. D., Bechara, A., Garavan, H., Childress, A. R., Paulus, M. P., and Volkow, N.D. (2009). The neurocircuitry of impaired insight in drug addiction. Trends Cogn. Sci. (Regul. Ed.) 13, 372-380.
27. Hall, W., and Degenhardt, L. (2011). Cannabis and the increased incidence and persistence of psychosis. BMJ 342, d719.
28. Hester, R., Nestor, L., and Garavan, H. (2009). Impaired error awareness and anterior cingulate cortex hypoactivity in chronic cannabis users. Neuropsychopharmacology 34, 2450-2458.
29. Hester, R., Simoes-Franklin, C., and Garavan, H. (2007). Post-error behavior in active cocaine users: poor awareness of errors in the presence of intact performance adjustments. Neuropsychopharmacology 32,1974-1984.
30. Husted, J. R. (1999). Insight in severe mental illness: implications for treatment decisions. J. Am. Acad. Psychiatry Law 27,33-49.
31. Jung, J. G., Kim, J. S., Kim, G. J., Oh, M. K., and Kim, S. S. (2011). Brief insight-enhancement intervention among patients with alcohol dependence. J. Korean Med. Sci. 26, 11-16.
32. Kalivas, P. W., and Volkow, N. D. (2005). The neural basis of addiction: a pathology of motivation and choice. Am. J. Psychiatry 162, 1403-1413.
33. Kao, Y. C., and Liu, Y. P. (2010). Compliance and schizophrenia: the predictive potential of insight into illness, symptoms, and side effects. Compr. Psychiatry 51,557-565.
34. Khoury, L., Tang, Y. L., Bradley, B., Cubells, J. F., and Ressler, K. J. (2010). Substance use, childhood traumatic experience, and posttrau-matic stress disorder in an urban civilian population. Depress. Anxiety 27, 1077-1086.
35. Kim, J. S., Kim, G. J., Lee, J. M., Lee, C. S., and Oh, J. K. (1998). HAIS (Hanil Alcohol Insight Scale): validation of an insight-evaluation instrument for practical use in alcoholism. J. Stud. Alcohol 59, 52-55.
36. Kim, K. M., Kim, J. S., Kim, G. J., Kim, S. S., Jung, J. G., Kim, S. M., Pack, H. J., and Lee, D. H. (2007). The readiness to change and insight in alcohol dependent patients. J. Korean Med. Sci. 22, 453-458.
37. Kokoszka, A., Telichowska-Lesna, A., and Radzio, R. (2008). A questionnaire of insight into schizophrenia-"my thoughts and feelings". Psychiatr. Pol. 42, 491-502.
38. Krausz, M., Degkwitz, P., Haasen, C., and Verthein, U. (1996). Opioid addiction and suicidality. Crisis 17, 175-181.
39. Kuepper, R., van Os, J., Lieb, R., Wittchen, H. U., Hofler, M., and Henquet, C. (2011). Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study. BMJ 342, d738.
40. Lahmeyer, H. W., Channon, R. A., and Schlemmer, E J. (1988). "Psychoac-tive Substance Abuse," in Psychiatry Diagnosis and Tgerapy, eds J. A. Flaherty, R. A. Channon, and J. M. Devis (San Mateo, CA: Appleton and Lange), 182-199.
41. Large, M., Sharma, S., Compton, M. T., Slade, T., and Nielssen, O. (2011). Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Arch. Gen. Psychiatry 68, 555-561.
42. Levinson, I., Galynker, I. I., and Rosen-thal, R. N. (1995). Methadone withdrawal psychosis. J. Clin. Psychiatry 56, 73-76.
43. Lubrano, S., Pacini, M., Giuntoli, G., and Maremmani, I. (2002). Is craving for heroin and alcohol related to low methadone dosages in methadone maintained patients? Heroin Addict. Relat. Clin. Probl. 4, 11-17.
44. Marazziti, D., Dell'Osso, L., Di Nasso, E., Pfanner, C., Presta, S., Mungai, E, and Cassano, G. B. (2002). Insight in obsessive-compulsive disorder: a study of an Italian sample. Eur. Psychiatry 17, 407-410.
45. Maremmani, A. G. I., Dell'Osso, L., Pacini, M., Popovic, D., Rovai, L., Torrens, M., Perugi, G., and Maremmani, I. (2011). Dual diagnosis and chronology of illness in 1090 treatment seeking Italian heroin dependent patients. J. Addict. Dis. 30, 123-135.
46. Maremmani, I. (2008). When a new drug promotes the integration of treatment modalities: suboxone and harm reduction. Heroin Addict. Relat. Clin. Probl. 10, 5-12.
47. Maremmani, I., Canoniero, S., and Pacini, M. (2002). Psycho (patho)logy of "addiction." Interpretative hypothesis. Ann. Ist. Super. Sanita 38, 241-257.
48. Maremmani, I., and Castrogiovanni, P. (1989). DAH-Q: Drug Addiction Questionnaire. Pisa: University Press.
49. Maremmani, I., Marini, G., and For-nai, E (1998). Naltrexone-induced panic attacks. Am. J. Psychiatry 155, 447.
50. Maremmani, I., Pacini, M., Popovic, D., Romano, A., Maremmani, A. G., Perugi, G., Deltito, J., Akiskal, K., and Akiskal, H. (2009). Affective temperaments in heroin addiction. J. Affect. Disord. 117, 186-192.
51. Maremmani, I., Pani, P. P., Canoniero, S., Pacini, M., Perugi, G., Rihmer, Z., and Akiskal, H. S. (2007a). Is the bipolar spectrum the psychopatho-logical substrate of suicidality in heroin addicts? Psychopathology 40, 269-277.
52. Maremmani, I., Pani, P. P., Mellini, A., Pacini, M., Marini, G., Lovre-cic, M., Perugi, G., and Shinderman, M. (2007b). Alcohol and cocaine use and abuse among opioid addicts engaged in a methadone maintenance treatment program. J. Addict. Dis. 26, 61-70.
53. Toward a unitary perspective on the bipolar spectrum and substance abuse: opiate addiction as a paradigm
54. Maremmani, I., and Popovic, D. (2009). "Heroin dependence," in The Principles and Practice of Methadone Treatment, ed. I. Maremmani (Pisa: Pacini Editore Medicina), 21-30.
55. Maremmani, I., Zolesi, O., Aglietti, M., Marini, G., Tagliamonte, A., Shinderman, M., and Maxwell, S. (2000). Methadone dose and retention during treatment of heroin addicts with axis I psychiatric comorbidity. J. Addict. Dis. 19, 29-41.
56. Markova, I. (2005). Insight in Psychiatry. Cambridge, NY: Cambridge University Press.
57. Marks, K. A., Fastenau, P. S., Lysaker, P. H., and Bond, G. R. (2000). Self-Appraisal of Illness Questionnaire (SAIQ): relationship to researcher-rated insight and neuropsychological function inschizophrenia. Schizophr. Res. 45, 203-211.
58. Martinotti, G., Carli, V., Tedeschi, D., Di Giannantonio, M., Roy, A., Janiri, L., and Sarchiapone, M. (2009). Mono- and polysubstance dependent subjects differ on social factors, childhood trauma, personality, suicidal behaviour, and comorbid axis I diagnoses. Addict. Behav. 34, 790-793.
59. Miller, R., Caponi, J. M., Sevy, S., and Robinson, D. (2005). The insight-adherence-abstinence triad: an integrated treatment focus for cannabis-using first-episode schizophrenia patients. Bull. Menninger Clin. 69, 220-236.
60. Moeller, S. J., Maloney, T., Parvaz, M. A., Alia-Klein, N., Woicik, P. A., Telang, F., Wang, G. J., Volkow, N. D., and Goldstein, R. Z. (2010). Impaired insight in cocaine addiction: laboratory evidence and effects on cocaine-seeking behaviour. Brain 133, 1484-1493.
61. Naqvi, N. H., and Bechara, A. (2010). The insula and drug addiction: an interoceptive view of pleasure, urges, and decision-making. Brain Struct. Funct. 214, 435-450.
62. Pacini, M., Maremmani, I., Vitali, M., Santini, P., Romeo, M., and Cecca-nti, M. (2009). Affective temperaments in alcoholic patients. Alcohol 43, 397-404.
63. Pallanti, S., Quercioli, L., Pazzagli, A., Rossi, A., Dell'Osso, L., Pini, S., and Cassano, G. B. (1999). Awareness of illness and subjective experience of cognitive complaints in patients with bipolar I and bipolar II disorder. Am. J. Psychiatry 156, 1094-1096.
64. Pani, P. P., Agus, A., and Gessa, G. L. (1999). Methadone as a mood stabilizer. Heroin Addict. Relat. Clin. Probl. 1,43-44.
65. Pani, P. P., Maremmani, I., Trogu, E., Gessa, G. L., Ruiz, P., and Akiskal, H. S. (2010). Delineating the psychic structure of substance abuse and addictions: should anxiety, mood and impulse-control dysregulation be included? J. Affect. Disord. 122, 185-197.
66. Perugi, G., Akiskal, H. S., Micheli, C., Musetti, L., Paiano, A., Quilici, C., Rossi, L., and Cassano, G. B. (1997). Clinical subtypes of bipolar mixed states: validating a broader European definition in 143 cases. J. Affect. Disord. 43, 169-180.
67. Perugi, G., Frare, F., Madaro, D., Maremmani I., and Akiskal, H.S. (2002). Alcohol abuse in social phobic patients: is there a bipolar connection? J. Affect. Disord. 68, 33-39.
68. Perugi, G., Musetti, L., Simonini, E., Piagentini, F., Cassano, G. B., and Akiskal, H. S. (1990). Gender mediated clinical features of depressive illness. The importance of temperamental differences. Br. J. Psychiatry 157, 835-841.
69. Pini, S., Cassano, G. B., Dell'Osso, L., and Amador, X. E (2001). Insight into illness in schizophrenia, schizoaffective disorder, and mood disorders with psychotic features. Am. J. Psychiatry 158, 122-125.
70. Roncone, R., Tozzini, C., Mazza, M., de Risio, A., Giosue, P., Morosini, P., and Casacchia, M. (2003). Validation of the Italian version of the self-report insight scale. Epidemiol. Psichiatr. Soc. 12, 63-75.
71. Schneider, K. (1958). Psychopathic Personalities. Springfield, IL: Charles C. Thomas.
72. Segarra, R., Ojeda, N., Pena, J., Garcia, J., Rodriguez-Morales, A., Ruiz, I., Hidalgo, R., Buron, J. A., Eguiluz, J. I., and Gutierrez, M. (2010). Longitudinal changes of insight in first episode psychosis and its relation to clinical symptoms, treatment adherence and global functioning: one-year follow-up from the Eiffel study. Eur. Psychiatry 27, 43-49.
73. Sevy, S., Robinson, D. G., Napolitano, B., Patel, R. C., Gunduz-Bruce, H., Miller, R., McCormack, J., Lorell, B. S., and Kane, J. (2010). Are cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia. Schizophr. Res. 120, 101-107.
74. Spensley, J. (1976). Doxepin: a useful adjunct in the treatment of heroin addicts in a methadone program. Int. J. Addict. 11, 191-197.
75. Stine, S. M., Freeman, M., Burns, B., Charney, D. S., and Kosten, T. R. (1992). Effects of methadone dose on cocaine abuse in a methadone program. Am. J. Addict. 1, 294-303.
76. Tennant, F., and Shannon, J. (1995). Cocaine abuse in methadone maintenance patients is associated with low serum methadone concentration. J. Addict. Dis. 14, 67-74.
77. Varga, E., Sugerman, A. A., and Apter, J. (1982). The effect of codeine on involutional and senile depression. Ann. N. Y. Acad. Sci. 398, 103-105.
78. Varga, M., Magnusson, A., Flekkoy, K., Ronneberg, U., and Opjordsmoen, S. (2006). Insight, symptoms and neurocognition in bipolar I patients. J. Affect. Disord. 91, 1-9.
79. Vender, S., and Poloni, N. (2006). Is the insight a favourable prognostic factor in the treatment of mental disorders? Recenti. Prog. Med. 97, 565-570.
80. Verdejo-Garcia, A., and Perez-Garcia, M. (2008). Substance abusers' self-awareness of the neurobehavioralconsequences of addiction. Psychiatry Res. 158,172-180.
81. Yen, C. F., Hsiao, R. C., Chen, C. C., Lin, H. C., Yen, C. N., Ko, C. H., Yen, J. Y., and Chen, C. S. (2009). The role of insight to alcohol use disorders in insight to schizophrenia. Compr. Psychiatry 50, 58-62.